Abstract
Objectives: A single diagnostic code could be used to perform surveillance for opioid-associated amnestic syndrome (OAS) in healthcare datasets on a national scale. Methods: A request was submitted to search the Discharge Abstract Database (DAD) and the National Ambulatory Care Reporting System (NACRS) in Canada for the ICD-10-CA code, F11.6 (mental and behavioural disorders due to use of opioids, amnesic syndrome) during fiscal years (FY) 2010-2011 through 2022-2023. The annual total of encounters using this code was determined and crude rates per million were calculated for the Canadian population represented. Results: National counts from DAD and NACRS combined ranged from <5 to 14 annually. Rates per million for available years fell between 0.17 and 0.48. For available data through FY 2015-2016, the mean number of annual combined encounters nationally was 6.3; for those years after, the mean was 10. The mean rate per million was 0.23 and 0.35 for these two periods, respectively. Discussion: This study represents the first effort to conduct surveillance for OAS on a national scale and suggests that the condition is relatively rare. Future efforts to validate the coded diagnosis of OAS with confirmed cases will help determine its value as a surveillance tool.

This publication has 10 references indexed in Scilit: